tirzepatide surpass SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of SURPASS-CVOT Shows Mounjaro Surpasses Trulicity

Its best to take it easy by drinking small volumes of liquids more frequently

Intervertebral Disc Degeneration GLP-1 protects nucleus pulposus cells (NPCs) ( the primary cell type driving disc integrity) by inhibiting AP-1driven catabolic gene transcription (specifically BATF/JUN heterodimers that drive MMP13 and ADAMTS5), curtailing NF-B via SIRT1 upregulation, and differentially modulating STAT3 (suppressing pathological senescence in NPCs while promoting M2 macrophage polarization)

et al., 2023), suggesting that GLP-1R may influence AD progression by modulating metabolic pathways associated with DM

Both semaglutide and tirzepatide contain Aib residues in their structures to improve their stability against proteases (Section )

Bloating is one of the most common and least discussed side effects of semaglutide therapy

In a 2024 randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine, which is one of our most prestigious journals, adults with obesity and moderate knee osteoarthritis received once weekly semaglutide or placebo for over a year, along with lifestyle counseling